Pathways to the diagnosis of ovarian cancer in the UK: a cohort study in primary care

BJOG. 2010 Apr;117(5):610-4. doi: 10.1111/j.1471-0528.2010.02499.x. Epub 2010 Jan 29.

Abstract

Objective: To identify the routes patients with ovarian cancer take between first symptom presentation and diagnosis.

Design: Cohort study.

Setting: The study took place in 39 general practices in Devon, UK.

Population: All ovarian cancer patients identified in the practices, with a diagnosis between 2000 and 2007 inclusive.

Methods: All patients had their cancer symptoms, referrals, and diagnoses identified and dated using their doctors' records.

Main outcome measures: Numbers of patients taking specific routes to diagnosis, together with the time taken to diagnosis.

Results: Three main routes to diagnosis emerged. The first was the expected route of outpatient referral: 195 (92% of the total) had at least one of the seven ovarian cancer symptoms or an abdominal mass. A total of 123 (58%) were referred to a specialist, although only 65 (31%) were referred to a gynaecologist. Thirty-five (17%) were initially investigated within primary care by ultrasound scanning, and a further 35 (17%) were admitted as emergencies. The interval from first symptom to referral was similar across the different pathways, with a median (interquartile range) time between the first symptom presenting to primary care and first investigation or referral being 2.5 (0, 27.5) days. The median interval from first symptom reported in primary care to diagnosis was 74.5 (32, 159) days.

Conclusions: Only a minority of ovarian cancer patients follow the expected route to diagnosis, of urgent referral to a gynaecologist. In most women, GPs rapidly identified the need to investigate. Avoidable delays generally occurred after the decision to investigate was made.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • CA-125 Antigen / metabolism
  • Critical Pathways / statistics & numerical data
  • Family Practice / statistics & numerical data*
  • Female
  • Hospitalization / statistics & numerical data
  • Humans
  • Middle Aged
  • Ovarian Neoplasms / diagnosis*
  • Referral and Consultation
  • Time Factors

Substances

  • CA-125 Antigen